54
Participants
Start Date
December 1, 2020
Primary Completion Date
February 18, 2025
Study Completion Date
February 18, 2025
Ceralasertib
Tablets will be administered orally
Research Site, New York
Research Site, Ephrata
Research Site, Philadelphia
Research Site, Dijon
Research Site, Baltimore
Research Site, Madrid
Research Site, Myrtle Beach
Research Site, Bordeaux
Research Site, Tampa
Research Site, Indianapolis
Research Site, Ann Arbor
Research Site, Vandœuvre-lès-Nancy
Research Site, Lyon
Research Site, Las Vegas
Research Site, Los Angeles
Research Site, Duarte
Research Site, San Francisco
Research Site, Barcelona
Lead Sponsor
AstraZeneca
INDUSTRY